Friday, January 18, 2019

ACMD gets six new members

Six new members are appointed to the the Advisory Council for the Misuse of Drugs (ACMD), which makes recommendations to government on the...

May narrowly survives no confidence vote; parleys to break the impasse on

Prime Minister Theresa May won a confidence vote in the British parliament on Wednesday and then appealed to lawmakers from across the...

Drug dilemma of a no-deal Brexit

Britain is due to leave the European Union in 10 weeks' time but it still has no clear way out of the...

Ireland works to lessen Brexit impact on drug supplies

Ireland has drawn up a list of 24 medicines whose supply would be most vulnerable if Britain fails to conclude a Brexit divorce...

Brexit deal defeated by 230 votes; May faces no confidence vote

Prime Minister Theresa May's government faced a no confidence vote on Wednesday after the crushing defeat of her Brexit divorce deal by...

RPS begins consultation on professional standards for community pharmacy

The Royal Pharmaceutical Society (RPS) will start the work on the first ever Professional Standards for Community Pharmacy Services with a consultation...

Ruth Bednall nominated as new UKCPA Chair

Dr Ruth Bednall has taken up the position of Chair of the UK Clinical Pharmacy Association (UKCPA) after unanimous support from the UKCPA...

MedicinesComplete adds Palliative Care Formulary to the platform

Palliative Care Formulary (PCF), the go-to resource for healthcare professionals in palliative and hospice care, is now available on the MedicinesComplete platform.

HEE decision to cut salary support for pre-registration pharmacists flayed

Pharmacist organisations have condemned the reported decision of Health Education England (HEE) to cut the salary support for pre-registration pharmacists provided to...

Novartis migraine drug not cost effective: NICE

National Institute for Health and Care Excellence (NICE) on Thursday rejected Novartis's migraine drug Aimovig (erenumab) for now, concluding in a draft decision that...